| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Financial giants have made a conspicuous bullish move on Medtronic. Our analysis of options history for Medtronic (NYSE:MDT) revealed 12 unusual trades.
Delving into the details, we found 41% of traders were bullish, while 41% showed bearish tendencies. Out of all the trades we spotted, 7 were puts, with a value of $202,047, and 5 were calls, valued at $178,077.
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $85.0 to $105.0 for Medtronic over the recent three months.
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Medtronic's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Medtronic's substantial trades, within a strike price spectrum from $85.0 to $105.0 over the preceding 30 days.
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MDT | CALL | TRADE | BEARISH | 10/03/25 | $1.28 | $1.03 | $1.07 | $95.00 | $53.5K | 298 | 1.0K |
| MDT | CALL | TRADE | BEARISH | 10/03/25 | $0.99 | $0.96 | $0.96 | $95.00 | $37.7K | 298 | 400 |
| MDT | PUT | SWEEP | NEUTRAL | 01/15/27 | $9.2 | $8.9 | $8.99 | $95.00 | $34.2K | 71 | 38 |
| MDT | CALL | SWEEP | BEARISH | 01/16/26 | $1.1 | $0.87 | $0.87 | $105.00 | $31.4K | 4.1K | 378 |
| MDT | PUT | TRADE | BEARISH | 10/10/25 | $1.51 | $1.47 | $1.51 | $93.00 | $30.2K | 1.0K | 200 |
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
In light of the recent options history for Medtronic, it's now appropriate to focus on the company itself. We aim to explore its current performance.
5 market experts have recently issued ratings for this stock, with a consensus target price of $97.6.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access. * Maintaining their stance, an analyst from Wells Fargo continues to hold a Overweight rating for Medtronic, targeting a price of $100. * Consistent in their evaluation, an analyst from Citigroup keeps a Buy rating on Medtronic with a target price of $101. * Maintaining their stance, an analyst from Truist Securities continues to hold a Hold rating for Medtronic, targeting a price of $96. * An analyst from UBS persists with their Neutral rating on Medtronic, maintaining a target price of $95. * Consistent in their evaluation, an analyst from Baird keeps a Neutral rating on Medtronic with a target price of $96.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Medtronic with Benzinga Pro for real-time alerts.
Posted In: MDT
